Medicare Enrolled

Dr. Vinicius Costa Diniz Domingues, M.D.

Rheumatology · Daytona Beach, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
709 N CLYDE MORRIS BLVD, Daytona Beach, FL 32114
3862521632
Registered in NPPES since 2012
NPI: 1023364387 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Costa Diniz Domingues from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Costa Diniz Domingues? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Costa Diniz Domingues

Dr. Vinicius Costa Diniz Domingues is a rheumatology specialist in Daytona Beach, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Costa Diniz Domingues performed 1,024,972 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Costa Diniz Domingues received a total of $807,654 from 58 pharmaceutical and/or device companies across 1940 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Costa Diniz Domingues is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ Top 0% volume in FL $807,654 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 130111 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,024,972
Medicare services
Top 0% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
983,800 $4 $13
Romosozumab injection (Evenity) for osteoporosis 28,140 $8 $12
Denosumab injection (Prolia/Xgeva) 6,300 $18 $35
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
5,158 $56 $189
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,188 $94 $270
New patient office visit, complex (60-74 min) 187 $162 $521
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
145 $1 $15
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
29 $50 $175
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
25 $10 $64
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$807,654
Total received (2018-2024)
Avg $115,379/year across 7 years
Top 2% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,940
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$133,594
2023
$220,536
2022
$158,373
2021
$112,471
2020
$86,930
2019
$75,666
2018
$20,084

Payments by company (2024)

ABBVIE INC.
$40,869
Amgen Inc.
$22,649
GENZYME CORPORATION
$20,206
Janssen Biotech, Inc.
$17,632
GlaxoSmithKline, LLC.
$11,394
Lilly USA, LLC
$9,549
Aurinia Pharma U.S., Inc.
$7,009
UCB, Inc.
$1,483
UCB SA
$920
AstraZeneca Pharmaceuticals LP
$672
PFIZER INC.
$409
Novartis Pharmaceuticals Corporation
$224
Radius Health, Inc.
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
Regeneron Healthcare Solutions, Inc.
$90
Sandoz Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$43
Organon Llc
$40
SCILEX PHARMACEUTICALS INC.
$35
E.R. Squibb & Sons, L.L.C.
$29
Kiniksa Pharmaceuticals International, plc
$28
Pharming Healthcare, Inc.
$19
Grifols USA, LLC
$18
Top 3 companies account for 62.7% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$249,659
Horizon Therapeutics plc
$105,982
ABBVIE INC.
$91,064
GENZYME CORPORATION
$60,407
AbbVie Inc.
$59,603
GlaxoSmithKline, LLC.
$43,714
Aurinia Pharma U.S., Inc.
$37,988
UCB, Inc.
$32,987
AstraZeneca Pharmaceuticals LP
$29,626
Janssen Biotech, Inc.
$29,394
Amgen Inc.
$25,012
Novartis Pharmaceuticals Corporation
$9,225
Janssen Scientific Affairs, LLC
$6,280
Regeneron Pharmaceuticals, Inc.
$6,118
AbbVie, Inc.
$4,156
PFIZER INC.
$3,262
E.R. Squibb & Sons, L.L.C.
$2,416
Eli Lilly and Company
$2,389
Janssen Global Services, LLC
$2,000
UCB SA
$920
Radius Health, Inc.
$806
Boehringer Ingelheim Pharmaceuticals, Inc.
$667
Octapharma USA, Inc.
$628
Celgene Corporation
$423
Horizon Pharma plc
$360
SANOFI-AVENTIS U.S. LLC
$329
Regeneron Healthcare Solutions, Inc.
$261
Genentech USA, Inc.
$251
Mallinckrodt Hospital Products Inc.
$224
Mallinckrodt LLC
$201
Mallinckrodt Enterprises LLC
$168
Takeda Pharmaceuticals U.S.A., Inc.
$130
Genentech, Inc.
$102
Alexion Pharmaceuticals, Inc.
$99
Sobi, Inc
$87
kaleo, Inc.
$72
CSL Behring
$68
Pharming Healthcare, Inc.
$59
Grifols USA, LLC
$47
Sandoz Inc.
$44
Antares Pharma, Inc.
$42
Organon Llc
$40
Hikma Pharmaceuticals USA
$35
Eyevance Pharmaceuticals LLC
$35
SCILEX PHARMACEUTICALS INC.
$35
Kiniksa Pharmaceuticals International, plc
$28
Celltrion USA Inc.
$28
SOBI, INC
$28
Merck Sharp & Dohme Corporation
$18
Bioventus LLC
$18
ANI Pharmaceuticals, Inc.
$17
Actelion Pharmaceuticals US, Inc.
$17
Shire North American Group Inc
$16
Merck Sharp & Dohme LLC
$16
MEDAC PHARMA, INC.
$15
MEDEXUS PHARMA, INC.
$13
Ultragenyx Pharmaceutical Inc.
$12
Phadia US Inc.
$12
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AUVI-Q · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CUTAQUIG · CUVITRU · CYLTEZO · Cimzia · DUPIXENT · Durolane · EVENITY · EVUSHELD · Enbrel · FASENRA · FORTEO · GAZYVA · HADLIMA · HUMIRA · HYQVIA · HYRIMOZ · Hizentra · Humira · INFLECTRA · ImmunoCAP · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tobradex ST · Tymlos · XELJANZ · XYOSTED · Xembify · YUFLYMA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Daytona Beach?
Compare rheumatologists in the Daytona Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
7
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
HALIFAX HEALTH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Costa Diniz Domingues is a mixed practice specialist, with above-average Medicare volume (top 0% in FL).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Costa Diniz Domingues experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Costa Diniz Domingues performed 983,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Costa Diniz Domingues receive payments from pharmaceutical companies?
Yes. Dr. Costa Diniz Domingues received a total of $807,654 from 58 companies across 1,940 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Costa Diniz Domingues's costs compare to other rheumatologists in Daytona Beach?
Dr. Costa Diniz Domingues's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Costa Diniz Domingues) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →